Retrieved March 15, 2025, from [ \- Link Opens in New Tab]( Maryland Poison Center
Say goodbye to low energyyour vibrant self is just an injection away
Eight major RCTs of GLP-1RAs have investigated the cardiovascular outcomes, including the ELIXA trial of lixisenatide (250), the EXSCEL trial of exenatide ER (251), the LEARDER trial of liraglutide (252), the SUSTAIN-6 trial of subcutaneous semaglutide (253), the HARMONY trial of albiglutide (228), the REWIND trial of dulaglutide (254), the PIONEER trial of oral semaglutide (255), and the SELECT trial of subcutaneous semaglutide (199)
This uncovers that regardless of carnitine levels, MAD may be a powerful option to reduce overall seizure severity in adults with epilepsy
Avoid leaving the blend at room temperature for extended periods, and check the what happens if tirzepatide gets warm guide if you suspect a temperature excursion
your provider will assess individual risk